# Cybin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cybin

- Industry: Biotechnology
- Headquarters: Toronto, Canada
- Website: www.cybin.com
- Total disclosed funding: $2.6M
- Latest round: Seed (Mar 1, 2020)
- Investors on record: 1

## About

Based in Toronto, Canada, and founded in 2019, Cybin Inc., formerly known as Clarmin Explorations Inc., develops psychedelic therapies for mental health disorders. The company was co-founded by Eric So, John Kanakis, and Paul Glavine. In August 2023, Cybin Inc., a portfolio company of Innovating Capital Management, Bail Capital, and Janus Henderson Investors, acquired Small Pharma Ltd. from ACF Investors.

The company's platform offers therapeutic development and innovative drug delivery systems. The company uses API Modification, Research and Develop, and Science Meets Technology for its therapeutic development.

The company generated revenue of CAD 0.86 million in its financial year 2020.

The acquisition enables Cybin Inc. to scale its intellectual property portfolio in psychedelic drug development.

## Funding rounds

- Seed, Mar 1, 2020, $2.6M — Innovating Capital

## Investors

- Innovating Capital (https://capitalatlas.ai/funds/innovating-capital) — Seed